Bio-rad Laboratories, Inc. Earnings

Bio-rad Laboratories, Inc.’s revenue fell -2.01% since last year same period to $667.5Mn in the Q4 2024. On a quarterly growth basis, Bio-rad Laboratories, Inc. has generated 2.74% jump in its revenue since last 3-months.

Bio-rad Laboratories, Inc.’s net profit fell -304.69% since last year same period to $-715.8Mn in the Q4 2024. On a quarterly growth basis, Bio-rad Laboratories, Inc. has generated -209.59% fall in its net profits since last 3-months.

Bio-rad Laboratories, Inc.’s net profit margin fell -308.88% since last year same period to -107.24% in the Q4 2024. On a quarterly growth basis, Bio-rad Laboratories, Inc. has generated -206.67% fall in its net profit margins since last 3-months.

Bio-rad Laboratories, Inc.’s earning per share (EPS) estimates for the current quarter stand at 2.88 - a 148.63% jump from last quarter’s estimates.

Bio-rad Laboratories, Inc.’s earning per share (EPS) estimates for the current year stand at 2.88.

Bio-rad Laboratories, Inc.’s earning per share (EPS) fell -6.45% since last year same period to 2.9 in the Q4 2024. This indicates that the Bio-rad Laboratories, Inc. has generated -6.45% annual rate of fall in its earning per share (EPS) in the last 4 quarters.